Corticosteroid Lumbar Epidural Analgesia for Radiculopathy

Lumbosacral Radicular Pain Clinical Trial

Official title:
Corticosteroid Lumbar Epidural Analgesia for Radiculopathy (C.L.E.A.R.)

Status Completed

Clinical Trial Summary

This is a research study of SP-102, an experimental medication designed to relieve pain in patients with a specific type of leg pain. The medication is given once by your healthcare professional, with a possibility of a second injection as early as about 1 month after the first treatment. The purpose of the study is to measure how well a single injection of the experimental medication, SP-102, relieves pain. The study will also investigate the side effects of SP-102.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03372161
Study type	Interventional
Source	Scilex Pharmaceuticals, Inc.
Contact
Status	Completed
Phase	Phase 3
Start date	December 8, 2017
Completion date	January 6, 2022

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT03057197` - The Influence of Needle-insertion Depth on Successful Epidurogram and Clinical Outcome in Caudal Epidural Injections	N/A
Completed	`NCT02867046` - The Incidence of the Intravascular Injection During S1 Transforaminal Epidural Steroid Injection in Two Approaches: Medial vs Lateral in Anteroposterior View	N/A
Completed	`NCT01926470` - The Incidence of the Intravascular Injection During S1 Transforaminal Epidural Steroid Injection in Two Approaches: Anteroposterior Versus Oblique	N/A
Completed	`NCT03613662` - A Research Study to Characterize the Pharmacodynamics and Safety of Repeat Dose SP-102	Phase 2